GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (NAS:PACB) » Definitions » PS Ratio

Pacific Biosciences of California (Pacific Biosciences of California) PS Ratio : 2.33 (As of May. 05, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Pacific Biosciences of California PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Pacific Biosciences of California's share price is $1.83. Pacific Biosciences of California's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.79. Hence, Pacific Biosciences of California's PS Ratio for today is 2.33.

The historical rank and industry rank for Pacific Biosciences of California's PS Ratio or its related term are showing as below:

PACB' s PS Ratio Range Over the Past 10 Years
Min: 1.87   Med: 8.96   Max: 113.08
Current: 2.33

During the past 13 years, Pacific Biosciences of California's highest PS Ratio was 113.08. The lowest was 1.87. And the median was 8.96.

PACB's PS Ratio is ranked better than
62.28% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 3.23 vs PACB: 2.33

Pacific Biosciences of California's Revenue per Sharefor the three months ended in Dec. 2023 was $0.22. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.79.

During the past 12 months, the average Revenue per Share Growth Rate of Pacific Biosciences of California was 38.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 20.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 5.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was -2.50% per year.

During the past 13 years, Pacific Biosciences of California's highest 3-Year average Revenue per Share Growth Rate was 38.90% per year. The lowest was -22.00% per year. And the median was 7.10% per year.

Back to Basics: PS Ratio


Pacific Biosciences of California PS Ratio Historical Data

The historical data trend for Pacific Biosciences of California's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California PS Ratio Chart

Pacific Biosciences of California Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.62 57.52 32.02 14.33 12.40

Pacific Biosciences of California Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.33 19.83 21.59 12.10 12.40

Competitive Comparison of Pacific Biosciences of California's PS Ratio

For the Medical Devices subindustry, Pacific Biosciences of California's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's PS Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's PS Ratio falls into.



Pacific Biosciences of California PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Pacific Biosciences of California's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=1.83/0.787
=2.33

Pacific Biosciences of California's Share Price of today is $1.83.
Pacific Biosciences of California's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.79.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Pacific Biosciences of California  (NAS:PACB) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Pacific Biosciences of California PS Ratio Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Biosciences of California (Pacific Biosciences of California) Business Description

Traded in Other Exchanges
Address
1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.
Executives
Oene Mark Van officer: Chief Operating Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Christian O Henry director 9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121
David W Meline director 3M COMPANY, 3M OFFICE OF GENERAL COUNSEL, ST PAUL MN 55144-1000
Susan G. Kim officer: Chief Financial Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Jeff Eidel officer: See Remarks 1305 O'BRIEN DR., MENLO PARK CA 94025
Michele Farmer officer: Chief Accounting Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
William W. Ericson director 777 MARINERS ISLAND BOULEVARD, SUITE 550, SAN MATEO CA 94404
Peter Fromen officer: Chief Commercial Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Hannah Valantine director 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Michael Hunkapiller director 400 HAMILTON AVENUE, 4TH FLOOR, PALO ALTO CA 94301
Eric Schaefer officer: VP Chief Accounting Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Kathy Ordonez director 3 GIRALDA FARMS, C/O QUEST DIAGNOSTICS, MADISON NJ 07940
Randall S Livingston director
Lucy Shapiro director 10210 GENETIC CENTER COURT, SAN DIEGO CA 92121
David Botstein director 1380 WILLOW ROAD, PACIFIC BIOSCIENCES OF CALIFORNIA INC, MENLO PARK CA 94025